ArticleBone marrow transplantation2013

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse.

M Hoegh-Petersen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.